Re: 'efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis' by Deng et al.

被引：3
|
作者：
Zeng, Guangting [1 ,2 ]
Liu, Jing [1 ]
Liu, Shulan [1 ]
机构：
[1] Xiangnan Univ, Peoples Hosp Chenzhou 1, Dept Pharm, Chenzhou, Peoples R China
[2] Xiangnan Univ, Peoples Hosp Chenzhou 1, Dept Pharm, Chenzhou, Hunan, Peoples R China
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2023年 / 29卷 / 06期
关键词：
COVID-19; Efficacy; Fluvoxamine; Safety; Selective serotonin reuptake inhibitors;
D O I：
10.1016/j.cmi.2023.01.024
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：814 / 814
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis
    Deng, Jiawen
    Rayner, Daniel
    Ramaraju, Harikrishnaa B.
    Abbas, Umaima
    Garcia, Cristian
    Heybati, Kiyan
    Zhou, Fangwen
    Huang, Emma
    Park, Ye-Jean
    Moskalyk, Myron
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (05) : 578 - 586
  • [2] Assessing the Efficacy and Safety of Selective Serotonin Reuptake Inhibitors for Managing COVID-19 Patients: A Systematic Review and Meta-Analysis
    Zhou, F.
    Deng, J.
    Rayner, D.
    Ramaraju, H.
    Abbas, U.
    Huang, E.
    Lohit, S.
    Heybati, K.
    Garcia, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [3] Comment on Zhou et al.: Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis
    Charles Khouri
    Marion Lepelley
    Michel Mallaret
    Osteoporosis International, 2022, 33 : 2653 - 2655
  • [4] Comment on Zhou et al.: Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis
    Khouri, Charles
    Lepelley, Marion
    Mallaret, Michel
    OSTEOPOROSIS INTERNATIONAL, 2022, 33 (12) : 2653 - 2655
  • [5] Re: 'Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis' by Tleyjeh et al
    Koeckerling, David
    Pan, Daniel
    Barker, Joseph
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (08) : 1175 - 1176
  • [6] The effect of selective serotonin and norepinephrine reuptake inhibitors on clinical outcome of COVID-19 patients: A systematic review and meta-analysis
    Firouzabadi, Dena
    Kheshti, Fatemeh
    Abdollahifard, Saeed
    Taherifard, Erfan
    Kheshti, Mohammad Reza
    HEALTH SCIENCE REPORTS, 2022, 5 (06)
  • [7] Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: author's response
    Deng, Jiawen
    Affan, Eesha
    Garcia, Cristian
    Heybati, Kiyan
    Zhou, Fangwen
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (06) : 815 - 816
  • [8] Re: COVID-19 mortality among selective serotonin reuptake inhibitor users by Stauning et al.
    Rus, Carla P.
    Kooij, J. J. Sandra
    CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (06) : 836 - 837
  • [9] Selective serotonin reuptake inhibitors in stroke: a systematic review and meta-analysis
    Mead, G. E.
    Hsieh, C. F.
    Lee, R.
    Kutlubaev, M.
    Claxton, A.
    Hankey, G.
    Hackett, M.
    INTERNATIONAL JOURNAL OF STROKE, 2012, 7 : 9 - 10
  • [10] Efficacy and Safety of JAK Inhibitors in COVID-19 Patients: A Systematic Review and Meta-analysis
    Mashina, M.
    Bugazia, S.
    Alzghoul, H.
    Kamal, I.
    Hashem, A.
    Mashina, R.
    Tawfik, A.
    Badawy, M.
    Alnasser, Y.
    Omar, Q. Alhaaj
    Bustamante-Soliz, D.
    Jantz, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
12345